Medical Device News Magazine

AppliedVR and Kernel Flow Announce Clinical Results Evaluating How Brain Changes During Virtual Reality Treatment of Chronic Pain

New feasibility study indicates that VR has the potential to drive physiological changes in the body and brain associated with pain relief

About Medical Device News Magazine

About Medical Device News Magazine. We are a digital publication founded in 2008 located in the United States.

Advertise with Medical Device News Magazine! Join Our #1 Family of Advertisers!

We pride ourselves on being the best-kept secret when it comes to distributing your news! Our unique digital approach enables us to circulate your...

AppliedVR

AppliedVR®, a medical device pioneer advancing a novel, virtual reality-based approach to medicine, and Kernel today announced a joint study measuring the impact of VR pain treatment on the brain. The study, which included a single-blind, sham-controlled design, compared brain activation patterns and physiological metrics before, during, and after VR experiences in people experiencing chronic low back pain (CLBP).

Research

The research used AppliedVR’s RelieVRx® medical device, an eight-week, skills-based program that helps chronic low back pain (CLBP) patients learn self-management skills, combined with Kernel Flow and FlowVR—a compact, affordable, TD-fNIRS brain measurement headset customized for use in VR—to measure brain hemodynamic changes associated with pain relief.

Participants

While participants in the RelieVRx and sham groups both experienced varying levels of pain relief after completing the eight-week treatment, researchers determined that participants in the RelieVRx group experienced enhanced brain activation coherence — change that previously has been related to reduced pain — from pre-to-post treatment. Those patients receiving the VR sham control demonstrated a decline in brain coherence. Additionally, those receiving treatment from the RelieVRx device achieved a slower breathing rate as compared to the sham VR group. These results suggest that active RelieVRx treatment can create physiological changes in the body and have an impact on coherent global brain activity.

Pain

Pain is subjective and hard to measure outside of patient-reported outcomes, but affordable and accessible brain imaging could help researchers and providers better understand a patient’s level of pain and the impact of an intervention. AppliedVR and Kernel plan to conduct clinical studies to uncover how RelieVRx as an intervention could drive certain physiological changes in breathing and brain patterns that have been linked to pain relief.

AppliedVR Co-founder and President Josh Sackman

“We’re committed to developing a significant body of scientific evidence that demonstrates how our RelieVRx program, which is rooted in self-regulation, cognitive behavioral therapy skills and mindfulness, engages the brain and can impact the experience of pain. While we know there can be a strong placebo effect, this feasibility study showed that only the active RelieVRx treatment created changes at a physiological and brain activity level, creating a strong foundation for future research.”

Chronic Pain Costs

Chronic pain costs the U.S. an estimated $635 billion each year and is a major contributing factor driving America’s opioid crisis. Research has suggested that more than 72 million Americans suffer from chronic low back pain, with the condition being a leading cause of disability.

Ryan Field, CEO of Kernel Flow

“This exciting research shows how our Kernel Flow technology can measure the brain and help quantify notoriously difficult to measure conditions. By unlocking insights into specific biomarkers related to chronic pain, we can continue to help the medical community better understand how treatments like RelieVRx can change the practice of pain medicine.”

This study is part of an ongoing collaboration between AppliedVR and Kernel. Both organizations will continue to deepen and expand their research to larger and more diverse populations.

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Other News

Ultrahuman Announces its App Store ‘PowerPlugs’ with the World’s First AFib Detection Technology on a Smart Ring

Recognizing each individual’s health journey is unique, PowerPlugs enable people to choose and focus on the aspects of their health that matter most. It’s designed for highly personalized health insights, ensuring that every individual can personalize their health tracking to their unique needs and goals.

VisionAir Solutions Celebrates Milestone and New Collaboration

This achievement marks VisionAir Solutions commitment to bringing technological innovation to pulmonary medicine. Since its acquisition by Theken Companies last year, VAS has over doubled its growth and continues to demonstrate industry adoption and the advantages of personalized healthcare.

ArisGlobal Reports | Newest Version of LifeSphere® Regulatory Platform Launches

Ann-Marie Orange, CIO & Global Head of R&D shares, “With more than 35 years of experience in life sciences technology, ArisGlobal is the only technology company offering strong Safety, Regulatory, and Quality Management solutions powered with next-generation cognitive computing, delivering unmatched interoperability across the R&D IT ecosystem. Over the last 18 months ArisGlobal has made significant investment in the strategic acquisitions of Amplexor Life Sciences and SPORIFY, along with technology R&D – and we’re not stopping.”